The primary injection treatment for Guillain-Barré Syndrome (GBS) is called Intravenous Immunoglobulin (IVIg) therapy.
Understanding IVIg Therapy
IVIg therapy is a crucial part of managing GBS. Here's a breakdown:
- What it is: IVIg delivers plasma from donors directly into the bloodstream via an IV.
- How it works: The donated antibodies help to modulate the immune system and reduce the attack on the nerves.
- Administration: It's administered intravenously, meaning directly into a vein.
